Cell Therapeutics & Technology
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
11
NCT03952923
CD19-CAR-T in B-cell Malignancies Patients
Phase: Phase 1
Role: Collaborator
Start: Aug 1, 2019
Completion: Mar 31, 2021
Loading map...